Evidence map›Paper›PMID 42123375›Full record

ArticleInternational journal of molecular sciences2026

An HPLC-Based Multi-Analyte Secretome Characterization Panel for Canine Adipose-Derived Mesenchymal/Stromal Stem Cells: Quantification of Adenosine, Kynurenine, IL-10, and TGF-β in Conditioned Media-A Pilot Feasibility Study.

Steven Garner, Emily Laughrun, Susan Mooney, Michael McCord, Seymone Batiste, Melinda Wharton, Rosa Bañuelos, Lori McCord

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Steven GarnerSafari Stem Cell Inc., League City, TX 77573, USA.
Emily LaughrunSafari Stem Cell Inc., League City, TX 77573, USA.
Susan MooneySafari Stem Cell Inc., League City, TX 77573, USA.
Michael McCordSafari Stem Cell Inc., League City, TX 77573, USA.
Seymone BatisteSafari Stem Cell Inc., League City, TX 77573, USA.
Melinda WhartonSafari Stem Cell Inc., League City, TX 77573, USA.
Rosa BañuelosSafari Veterinary Care Centers, League City, TX 77573, USA.
Lori McCordSafari Veterinary Care Centers, League City, TX 77573, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stromal/stem cells (MSCs) are increasingly explored for immune-mediated diseases, yet standardized analytical readouts that capture coordinated immunomodulatory output across complementary secretory pathways remain limited. Here, we report the feasibility of an HPLC-based multi-analyte secretome characterization panel that quantifies two small-molecule outputs-adenosine and kynurenine-alongside two immunomodulatory proteins-interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β)-in conditioned media from canine adipose-derived MSCs (cAD-MSCs). Canine immune-mediated hemolytic anemia (IMHA) was used as a disease context to motivate the selection of these analytes, given the pro-inflammatory cytokine environment characteristic of this condition. Three independent cAD-MSC lines were evaluated under baseline conditions and following cytokine stimulation with recombinant interferon-gamma (IFN-γ; 100 ng/mL) and tumor necrosis factor-alpha (TNF-α; 50 ng/mL), referred to herein as inflammatory priming or licensing. Conditioned media were collected at 72 h for metabolite analysis and 48 h for protein analysis, and quantified by HPLC using external calibration and peak integration. Across all three lines, licensing produced directionally consistent increases: mean adenosine increased 2.3-fold, mean kynurenine increased 3.1-fold, mean IL-10 increased 1.6-fold, and mean TGF-β increased 1.7-fold compared with unlicensed controls. Metabolite measurements for adenosine and kynurenine are reported with full chromatographic selectivity data; IL-10 and TGF-β measurements by reversed-phase HPLC with UV detection are presented as exploratory/semi-quantitative outputs and will require orthogonal confirmation (e.g., immunoassay) in future work. These findings are preliminary, derived from three independent donor lines with no comparator group, and are intended to support feasibility of the analytical framework rather than establish definitive performance specifications. Collectively, the data support the potential of a multi-analyte HPLC-based characterization panel to capture licensing-responsive secretory shifts across mechanistically complementary pathways, providing a foundation for expanded development and validation.

Indexed as

AdenosineAdipose TissueInterleukin-10KynurenineMesenchymal Stem CellsSecretomeTransforming Growth Factor betaAnimalsChromatography, High Pressure LiquidCulture Media, ConditionedDogsFeasibility StudiesPilot ProjectsAdenosineCulture Media, ConditionedInterleukin-10KynurenineTransforming Growth Factor betaadenosinecanine MSCsconditioned mediaHPLCIL-10IMHAimmune-mediated hemolytic anemiainflammatory primingkynureninemesenchymal stromal/stem cellssecretome characterizationTGF-β

Identifiers

PMID42123375
PMCPMC13163311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.